Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

INBS

Intelligent Bio Solutions (INBS)

Intelligent Bio Solutions Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INBS
DateTimeSourceHeadlineSymbolCompany
20/06/202422:30GlobeNewswire Inc.Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics SectorNASDAQ:INBSIntelligent Bio Solutions Inc
19/06/202407:28Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INBSIntelligent Bio Solutions Inc
19/06/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
18/06/202422:30GlobeNewswire Inc.Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening TechnologyNASDAQ:INBSIntelligent Bio Solutions Inc
13/06/202422:30GlobeNewswire Inc.Intelligent Bio Solutions Implements Strategic Reorganization Plan to Support Global Growth InitiativesNASDAQ:INBSIntelligent Bio Solutions Inc
12/06/202422:30GlobeNewswire Inc.Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening TechnologyNASDAQ:INBSIntelligent Bio Solutions Inc
08/06/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
06/06/202422:30GlobeNewswire Inc.Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024NASDAQ:INBSIntelligent Bio Solutions Inc
30/05/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
29/05/202422:30GlobeNewswire Inc.Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) StudyNASDAQ:INBSIntelligent Bio Solutions Inc
24/05/202407:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
23/05/202422:30GlobeNewswire Inc.Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective SolutionsNASDAQ:INBSIntelligent Bio Solutions Inc
21/05/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
17/05/202422:30GlobeNewswire Inc.Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety EventNASDAQ:INBSIntelligent Bio Solutions Inc
09/05/202406:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
08/05/202422:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INBSIntelligent Bio Solutions Inc
08/05/202422:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational HighlightsNASDAQ:INBSIntelligent Bio Solutions Inc
18/04/202422:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue ResultsNASDAQ:INBSIntelligent Bio Solutions Inc
11/04/202422:30GlobeNewswire Inc.Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge ReaderNASDAQ:INBSIntelligent Bio Solutions Inc
26/03/202423:30GlobeNewswire Inc.Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYCNASDAQ:INBSIntelligent Bio Solutions Inc
13/03/202410:30GlobeNewswire Inc.Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:INBSIntelligent Bio Solutions Inc
11/03/202423:30GlobeNewswire Inc.Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:INBSIntelligent Bio Solutions Inc
05/03/202409:26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INBSIntelligent Bio Solutions Inc
02/03/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
01/03/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
29/02/202400:30GlobeNewswire Inc.Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) PathwayNASDAQ:INBSIntelligent Bio Solutions Inc
21/02/202409:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
17/02/202400:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity RequirementNASDAQ:INBSIntelligent Bio Solutions Inc
15/02/202410:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INBSIntelligent Bio Solutions Inc
14/02/202412:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INBSIntelligent Bio Solutions Inc
 Showing the most relevant articles for your search:NASDAQ:INBS